Parkview Research Center at Parkview Regional Medical Center ( Site 0089), Fort Wayne
Indiana University Health Arnett Cancer Center ( Site 0076), Lafayette

Recrutement en coursPhase 3

Âges de 18 ans et plus · Tous sexes · Mis à jour le 25 sept. 2026 · NCT06312137

Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer

Community Health Network, Inc, Indianapolis
Community Health Network, Inc., Indianapolis
Community Health Network, Inc., Indianapolis

Recrutement en coursPhase 3

Âges de 18 ans et plus · Tous sexes · Mis à jour le 25 sept. 2026 · NCT07222566

A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With Platinum-Based Chemotherapy, for Common Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)

Fort Wayne Medical Oncology and Hematology, Fort Wayne
Investigative Clinical Research of Indiana, LLC, Noblesville

Recrutement en coursPhase 2

Âges de 18 ans et plus · Tous sexes · Mis à jour le 25 sept. 2026 · NCT06667076

A Study to Investigate Ubamatamab With and Without Marlotamig (REGN7075) in Adult Participants With Advanced/Metastatic Non-Small Cell Lung Cancer (NSCLC)

Franciscan Health, Munster

Recrutement en coursPhase 2

Âges de 18 ans et plus · Tous sexes · Mis à jour le 25 sept. 2026 · NCT07154290

Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer

Parkview Research Center at Parkview Regional Medical Center, Fort Wayne
Franciscan Health, Indianapolis

Recrutement en coursPhase 3

Âges de 18 ans et plus · Tous sexes · Mis à jour le 24 sept. 2026 · NCT06890598

Phase III, Open-label, Study of First-line Dato-DXd in Combination With Rilvegostomig for Advanced Non-squamous NSCLC With High PD-L1 Expression (TC ≥ 50%) and Without Actionable Genomic Alterations

Research Site, Noblesville

Recrutement en coursPhase 3

Âges de 18 ans et plus · Tous sexes · Mis à jour le 23 sept. 2026 · NCT06357533

Safety, Efficacy, and Pharmacokinetics of BNT327 in Combination With Chemotherapy and Other Investigational Agents for Lung Cancer

Fort Wayne Medical Oncology and Hematology, Inc., Fort Wayne
Indiana University Health University Hospital, Indianapolis

Recrutement en coursPhase 2/3

Âges de 18 ans et plus · Tous sexes · Mis à jour le 22 sept. 2026 · NCT06712316

Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors

Community Health Network, Indianapolis

Recrutement en coursPhase 1/2

Âges de 18 ans et plus · Tous sexes · Mis à jour le 22 sept. 2026 · NCT06128551

A Study of ASP546C in Adults With Gastroesophageal Cancer, Pancreatic Cancer or Other Solid Tumors

Indiana University (IU) Health - Multi-D Oncology Clinic, Indianapolis

Recrutement en coursPhase 1/2

Âges de 18 ans et plus · Tous sexes · Mis à jour le 22 sept. 2026 · NCT07488676

A Study of Adagrasib Plus Pembrolizumab Plus Chemotherapy vs. Placebo Plus Pembrolizumab Plus Chemotherapy in Participants With Previously Untreated Non-squamous Non-small Cell Lung Cancer With KRAS G12C Mutation (KRYSTAL-4)

Northwest Cancer Centers, P.C., Dyer
Parkview Research Center at Parkview Regional Medical Center, Fort Wayne

Recrutement en coursPhase 3

Âges de 18 ans et plus · Tous sexes · Mis à jour le 22 sept. 2026 · NCT06875310

A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advanced or Metastatic Squamous Non-small Cell Lung Cancer (NSCLC)

Research Site, Fort Wayne

Recrutement en coursPhase 3

Âges de 18 ans et plus · Tous sexes · Mis à jour le 18 sept. 2026 · NCT06692738

Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients With High PD-L1

Clinical Study Site, Indianapolis

Recrutement en coursPhase 3

Âges de 18 ans et plus · Tous sexes · Mis à jour le 18 sept. 2026 · NCT06767514

Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7

Goshen Center for Cancer Care, Goshen

Recrutement en coursPhase 2/3

Âges de 18 ans et plus · Tous sexes · Mis à jour le 16 sept. 2026 · NCT04613596

Prospective Study on Radiation Induced Cardiotoxicity Assessed By PET-CT for Locally Advanced Non-Small Cell Lung Cancer (NSCLC)

Indiana University Melvin and Bren Simon Comprehensive Cancer Center, Indianapolis

Recrutement en coursPhase 2

Âges de 18 ans et plus · Tous sexes · Mis à jour le 15 sept. 2026 · NCT07761910

A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer

Parkview Research Center at Parkview Regional Medical Center, Fort Wayne
Indiana University Melvin and Bren Simon Cancer Center, Indianapolis
Franciscan Health, Indianapolis
et 1 autres

Recrutement en coursPhase 3

Âges de 18 ans et plus · Tous sexes · Mis à jour le 8 sept. 2026 · NCT06119581

A Study of Tolododekin Alfa (ANK-101) in Combination With an Anti-PD-1/PD-L1 Antibody in Participants With Advanced Non-Small Cell Lung Cancer

Community Health Network, Indianapolis

Recrutement en coursPhase 1

Âges de 18 ans et plus · Tous sexes · Mis à jour le 2 sept. 2026 · NCT07027514

Phase III, Open-label Study of First-line Osimertinib With or Without Datopotamab Deruxtecan for EGFRm Locally Advanced or Metastatic Non-small Cell Lung Cancer

Research Site, Fort Wayne

Recrutement en coursPhase 3

Âges de 18 ans et plus · Tous sexes · Mis à jour le 26 août 2026 · NCT06350097

MOONRAY-01, A Study of LY3962673 in Participants With KRAS G12D-Mutant Solid Tumors

Community Health Network, Indianapolis

Recrutement en coursPhase 1

Âges de 18 ans et plus · Tous sexes · Mis à jour le 24 août 2026 · NCT06586515

A Phase 1 of CTX-8371 in Patients With Advanced Malignancies

Fort Wayne Medical Oncology and Hematology, Fort Wayne

Recrutement en coursPhase 1

Âges de 18 ans et plus · Tous sexes · Mis à jour le 28 juil. 2026 · NCT06150664

A Study of Sigvotatug Vedotin in Advanced Solid Tumors

UChicago Medicine - Northwest Indiana, Crown Point
Fort Wayne Medical Oncology and Hematology, Inc, Fort Wayne
Community Health Network, Inc, Indianapolis
et 3 autres

Recrutement en coursPhase 1

Âges de 18 ans et plus · Tous sexes · Mis à jour le 6 juil. 2026 · NCT04389632

LUNAR-2: TTFields With Pembrolizumab + Platinum-based Chemotherapy for Metastatic NSCLC

Parkview Packnett Family Cancer Institute, Fort Wayne
Franciscan Health Indianapolis, Indianapolis

Recrutement en coursPhase 3

Âges de 18 ans et plus · Tous sexes · Mis à jour le 25 juin 2026 · NCT06216301

Study to Assess Adverse Events and Pharmacokinetics in Adult Participants With Non-Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma and Other Solid Tumors, Receiving Intravenous Infusion of Azirkitug Alone or in Combination(s) With Budigalimab, Bevacizumab, or Telisotuzumab Adizutecan

Fort Wayne Medical Oncology and Hematology, Inc /ID# 232593, Fort Wayne
Community Health Network, Inc. /ID# 243011, Indianapolis

Recrutement en coursPhase 1

Âges de 18 ans et plus · Tous sexes · Mis à jour le 23 juin 2026 · NCT05005403

A Study of LY4175408 in Participants With Advanced Cancer

Community Health Network, Indianapolis

Recrutement en coursPhase 1

Âges de 18 ans et plus · Tous sexes · Mis à jour le 23 juin 2026 · NCT07046923

Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has Increased Copies of the MET Gene (An Expanded Lung-MAP Treatment Trial)

Indiana University/Melvin and Bren Simon Cancer Center, Indianapolis

Recrutement en coursPhase 2

Âges de 18 ans et plus · Tous sexes · Mis à jour le 6 mai 2026 · NCT06116682

Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)

Indiana University/Melvin and Bren Simon Cancer Center, Indianapolis

Recrutement en coursPhase 2

18 Minutes · Tous sexes · Mis à jour le 5 mai 2026 · NCT06031688

Adjuvant Pembrolizumab vs Observation Following Curative Resection for Stage I Non-small Cell Lung Cancer (NSCLC) With Primary Tumors Between 1-4 cm

Indiana University Melvin and Bren Simon Cancer Center, Indianapolis

Recrutement en coursPhase 2

Âges de 18 ans et plus · Tous sexes · Mis à jour le 5 mai 2026 · NCT04317534

Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)

Indiana University/Melvin and Bren Simon Cancer Center, Indianapolis
Richard L. Roudebush Veterans Affairs Medical Center, Indianapolis

Recrutement en coursPhase 2/3

Âges de 18 ans et plus · Tous sexes · Mis à jour le 5 mai 2026 · NCT06616584

A Study of VET3-TGI in Patients With Solid Tumors

Community Health Network, Indianapolis

Recrutement en coursPhase 1

Âges de 18 ans et plus · Tous sexes · Mis à jour le 7 avr. 2026 · NCT06444815

Source : ClinicalTrials.gov, données récupérées le 5 oct. 2026. Chaque étude définit ses propres critères d'éligibilité ; l'équipe de l'étude décide qui peut y participer.